Loading...
XTAI
4104
Market cap409mUSD
Jul 09, Last price  
69.80TWD
1D
0.72%
1Q
-10.51%
Jan 2017
80.92%
IPO
35.14%
Name

Excelsior Medical Co Ltd

Chart & Performance

D1W1MN
XTAI:4104 chart
P/E
16.32
P/S
1.50
EPS
4.28
Div Yield, %
5.44%
Shrs. gr., 5y
2.92%
Rev. gr., 5y
5.66%
Revenues
8.79b
+2.94%
14,300,782,00015,355,606,0005,994,336,0005,998,988,0005,740,961,0005,806,677,0006,202,884,0006,205,758,0006,095,337,0006,345,031,0006,457,362,0006,675,494,0006,573,152,0007,186,828,0008,233,404,0008,538,546,0008,789,236,000
Net income
806m
+4.49%
311,950,000355,692,000333,970,000275,785,000299,942,000285,681,000379,000,000389,557,000399,047,000451,562,000514,755,000571,670,000607,149,000667,453,000746,605,000771,259,000805,860,000
CFO
-1.19b
L
693,512,000-33,458,000-528,524,000717,257,000357,477,000736,736,000739,959,000449,713,000-487,388,000192,434,0001,194,496,000869,433,000945,049,000637,126,000107,101,0002,471,445,000-1,190,287,000
Dividend
Apr 24, 20253.99 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Excelsior Medical Co., Ltd. operates as a distributor of a diverse range of healthcare technology and products throughout various Asian nations, specifically Taiwan, mainland China, Japan, South Korea, Malaysia, and the Philippines. Its extensive portfolio encompasses specialized machinery for hemodialysis, routine pharmaceuticals for healthcare facilities, surgical instrumentation, and electronic aids for medical professionals, in addition to cosmetic devices. The company further extends its services to offer administrative support tailored for individual medical departments. Established in 1988, Excelsior Medical maintains its headquarters in New Taipei City, Taiwan.
URL
https://www.excelsiormedical.com.tw/
IPO date
Jun 08, 2001
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT